2025 Year-End Review: Performance of Publicly Traded Direct Selling Firms
The performance of publicly traded, product-focused direct selling companies in 2025 offers valuable insights into the evolving dynamics within the industry. This annual review highlights how these companies navigated challenges and opportunities, shedding light on field productivity, product relevance, and the competitive landscape.
Market Variability and Company Performance
The findings from 2025 reveal a significant divergence in performance among product-centric direct selling companies. While some firms regained momentum through innovative product offerings and geographic expansion, others struggled with diminishing distributor bases and fluctuating consumer demand. The persistent impacts of post-pandemic market shifts further complicated the landscape.
One notable trend is the variability in profitability across the sector. Net incomes among the companies reviewed ranged dramatically, from a few million dollars to upwards of $400 million for larger players. This disparity underscores the idea that revenue growth alone is insufficient; factors such as execution, distributor engagement, and product relevance are critical determinants of success.
Individual Company Performance
Herbalife Ltd. (NYSE: HLF)
2025 Revenue: $5.04 Billion
2025 Profit: $227.8 Million
2024 Revenue: $4.99 Billion
Change vs. 2024: +1.0%
Herbalife demonstrated stabilization and regained momentum in 2025. The company surpassed expectations for both net sales and adjusted EBITDA, while also enhancing its balance sheet through reduced leverage. A particularly encouraging sign was the return to growth in North America, indicating that its operational reset and distributor engagement initiatives are beginning to yield results.
The launch of the Protocol platform aims to modernize product architecture and enhance distributor interaction, suggesting a strategic focus on long-term engagement. Though not a breakout year, Herbalife's results reflect a commitment to operational consistency, setting the stage for gradual growth into 2026.
Nu Skin Enterprises (NYSE: NUS)
2025 Revenue: $1.49 Billion
2025 Profit: ~ $68 Million
2024 Revenue: $1.73 Billion
Change vs. 2024: -13.9%
Nu Skin faced significant challenges in 2025, experiencing a sharp decline in revenue as customer and affiliate numbers decreased across key markets. The contraction in its distributor base was a major contributor to this downturn.
In response, Nu Skin appointed a new Chief Operating Officer, Chayce Clark, to oversee revenue performance and operational execution. The management team is prioritizing restructuring and cost management to protect profitability while aiming to stabilize operations and restore growth momentum.
USANA Health Sciences (NYSE: USNA)
2025 Revenue: $925 Million
2025 Profit: ~ $60 Million
2024 Revenue: $855 Million
Change vs. 2024: +8.2%
USANA achieved modest revenue growth, largely credited to its acquisition of Hiya, a direct-to-consumer children's wellness brand. However, its traditional MLM operations continue to face declining sales, suggesting that the newer DTC segment is effectively compensating for challenges in its legacy distributor channel.
Management anticipates that the continued expansion of the Hiya brand will be pivotal for future growth, marking USANA as one of the few companies successfully integrating both direct selling and DTC models.
Nature’s Sunshine Products (NASDAQ: NATR)
2025 Revenue: $480.1 Million
2025 Profit: ~ $18 Million
2024 Revenue: $450 Million
Change vs. 2024: +6.7%
Nature’s Sunshine exhibited consistent performance, with revenue growth across multiple regions, including North America, Asia, and Europe. The company benefitted from operational efficiencies and favorable foreign exchange conditions, emphasizing steady international expansion as a key growth strategy.
LifeVantage Corp. (NASDAQ: LFVN)
2025 Revenue: $228.5 Million
2025 Profit: ~ $9-10 Million
LifeVantage's results will be further analyzed in subsequent reports, as they continue to adapt to the changing market dynamics.
Conclusion
The 2025 financial outcomes of these publicly traded product-centric direct selling companies illustrate a diverse landscape characterized by both challenges and opportunities. As the industry evolves, companies that prioritize product relevance, operational efficiency, and distributor engagement are likely to navigate the competitive waters more successfully.
